en
Scientific article
Open access
English

Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation

Published inPloS one, vol. 5, no. 4, e10352
Publication date2010
Abstract

BACKGROUND: Anti-CD154 (MR1) monoclonal antibody (mAb) and rapamycin (RAPA) treatment both improve survival of rat-to-mouse islet xenograft. The present study investigated the effect of combined RAPA/MR1 treatment on rat-to-mouse islet xenograft survival and analyzed the role of CD4(+)CD25(+)Foxp3(+) T regulatory cells (Treg) in the induction and maintenance of the ensuing tolerance. METHODOLOGY/PRINCIPAL FINDINGS: C57BL/6 mice were treated with MR1/RAPA and received additional monoclonal anti-IL2 mAb or anti CD25 mAb either early (0-28 d) or late (100-128 d) post-transplantation. Treg were characterised in the blood, spleen, draining lymph nodes and within the graft of tolerant and rejecting mice by flow cytometry and immunohistochemistry. Fourteen days of RAPA/MR1 combination therapy allowed indefinite islet graft survival in >80% of the mice. Additional administration of anti-IL-2 mAb or depleting anti-CD25 mAb at the time of transplantation resulted in rejection (100% and 89% respectively), whereas administration at 100 days post transplantation lead to lower rejection rates (25% and 40% respectively). Tolerant mice showed an increase of Treg within the graft and in draining lymph nodes early post transplantation, whereas 100 days post transplantation no significant increase of Treg was observed. Rejecting mice showed a transient increase of Treg in the xenograft and secondary lymphoid organs, which disappeared within 7 days after rejection. CONCLUSIONS/SIGNIFICANCES: These results suggest a critical role for Treg in the induction phase of tolerance early after islet xenotransplantation. These encouraging data support the need of developing further Treg therapy for overcoming the species barrier in xenotransplantation.

Keywords
  • Animals
  • Antibodies, Monoclonal/*pharmacology/therapeutic use
  • CD40 Ligand/*immunology
  • Graft Survival/drug effects
  • Immune Tolerance/*drug effects
  • Immunosuppressive Agents
  • Islets of Langerhans Transplantation/*immunology
  • Lymphocyte Count
  • Mice
  • Mice, Inbred C57BL
  • Rats
  • Sirolimus/*pharmacology/therapeutic use
  • T-Lymphocytes, Regulatory/*immunology
  • Time Factors
  • Transplantation, Heterologous
Citation (ISO format)
MULLER, Yannick et al. Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation. In: PloS one, 2010, vol. 5, n° 4, p. e10352. doi: 10.1371/journal.pone.0010352
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1932-6203
822views
352downloads

Technical informations

Creation05/22/2012 3:16:07 PM
First validation05/22/2012 3:16:07 PM
Update time03/14/2023 5:30:50 PM
Status update03/14/2023 5:30:50 PM
Last indexation02/12/2024 11:16:20 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack